The Anti-ROR1 Ziloverta Biosimilar (HDBS0067) is a cutting-edge antibody designed for research involving the Receptor tyrosine kinase-like orphan receptor 1 (ROR1). ROR1 is a transmembrane protein that plays a crucial role in cancer progression and metastasis, making it a promising target for cancer therapy.This biosimilar antibody, developed through advanced techniques, is highly specific and reactive with human samples, making it an excellent tool for studying the function of ROR1 in various cell types. Validated for use in Western blot applications, the antibody binds specifically to the ROR1 protein, enabling detailed detection and analysis in research focused on cancer biology and therapeutic development.
ROR1 has been identified as a potential target for cancer treatment due to its overexpression in various cancer types, including leukemia, breast cancer, and lung cancer. By understanding the role of ROR1 in promoting tumor growth and metastasis, researchers can develop targeted therapies that specifically inhibit ROR1 signaling pathways, leading to more effective and personalized cancer treatments.Overall, the Anti-ROR1 Ziloverta Biosimilar (HDBS0067) offers a valuable tool for researchers investigating the role of ROR1 in cancer biology, with the potential to drive advancements in precision medicine and targeted cancer therapies.
Product Name:
Zilovertamab (Anti-ROR1) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0067
Target:
ROR1
Host Species:
Humanized
Reactivity:
Human
Recommended Dilution:
ELISA 1:5000-10000; Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
UC-961,cirmtuzumab
Description:
Anti-ROR1 (zilovertamab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
ELISA, Flow Cyt
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
